Vir Biotechnology Inc
NASDAQ:VIR
Wall Street
Price Targets
VIR Price Targets Summary
Vir Biotechnology Inc
According to Wall Street analysts, the average 1-year price target for VIR is 30.09 USD with a low forecast of 10.1 USD and a high forecast of 115.5 USD.
VIR Last Price Targets
Vir Biotechnology Inc
The latest public price target was made on Aug 2, 2024 by Gena Wang from Barclays , who expects VIR stock to rise by 177% over the next 12 months. You can read more about this price target by viewing the article on TheFly.
Analyst | Price Target | Date | Article |
---|---|---|---|
Gena Wang
Barclays
|
28
USD
Upside 177% |
5 months ago
Aug 2, 2024
|
Vir Biotechnology price target raised to $28 from $27 at Barclays
TheFly
|
Michael Ulz
Morgan Stanley
|
15
USD
Upside 48% |
7 months ago
Jun 5, 2024
|
Vir Biotechnology (VIR) PT Raised to $15 at Morgan Stanley
StreetInsider
|
Gena Wang
Barclays
|
27
USD
Upside 167% |
8 months ago
May 21, 2024
|
Barclays Reiterates Overweight Rating on Vir Biotechnology (VIR)
StreetInsider
|
Paul Choi
Goldman Sachs
|
28.38
USD
Upside 181% |
1 year ago
Feb 21, 2023
|
DraftKings To Rally Around 38%? Here Are 10 Other Analyst Forecasts For Tuesday
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VIR's stock price target?
Price Target
30.09
USD
According to Wall Street analysts, the average 1-year price target for VIR is 30.09 USD with a low forecast of 10.1 USD and a high forecast of 115.5 USD.
What is Vir Biotechnology Inc's Revenue forecast?
Projected CAGR
-3%
For the last 5 years the compound annual growth rate for Vir Biotechnology Inc's revenue is 52%. The projected CAGR for the next 4 years is -3%.